Eurofins MWG Operon LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Eurofins MWG Operon LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10887
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eurofins MWG Operon LLC (Eurofins) is a DNA sequencing service provider. The company offers DNA sequencing services, DNA synthesis products, and bioinformatic services. Its product categories comprise DNA and RNA synthesis, DNA sequencing, GENE synthesis and next gen seq. Eurofins provides next gen DNA technology express oligos, extremer oligos, custom DNA oligos, custom RNA/chimeric oligos, NGS application oligos, QPCR / MGB probes, crisprs products, simax sirna, purification and yields and modifications. The company also offers sequencing dashboard, overnight sequencing, simpleseq kits, flexreads, tube sequencing, plate sequencing, fragment analysis, plasmid verification, clinical and GLP services and standard primers. The company has its presence in the US, India, Europe and Japan. Eurofins is headquartered in Louisville, Kentucky, the US.

Eurofins MWG Operon LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eurofins MWG Operon LLC, Medical Devices Deals, 2012 to YTD 2018 9
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Rubicon Genomics Enters into Distribution Agreeement with Eurofins MWG Operon 11
Eurofins MWG Operon And Floragenex Enter Into Co-Marketing Agreement For RAD Sequencing Services 12
Acquisition 13
Eurofins MWG Operon Acquires Entelechon, Gene Synthesis Provider 13
Eurofins MWG Operon LLC – Key Competitors 14
Eurofins MWG Operon LLC – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Other Significant Developments 16
Mar 14, 2017: Eurofins Genomics US Announces Commercial Launch of Next Generation DNA Synthesis Service 16
Jan 16, 2017: Eurofins Genomics Expands Express Oligo Service 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Key Facts 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eurofins MWG Operon LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Eurofins MWG Operon LLC, Medical Devices Deals, 2012 to YTD 2018 9
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rubicon Genomics Enters into Distribution Agreeement with Eurofins MWG Operon 11
Eurofins MWG Operon And Floragenex Enter Into Co-Marketing Agreement For RAD Sequencing Services 12
Eurofins MWG Operon Acquires Entelechon, Gene Synthesis Provider 13
Eurofins MWG Operon LLC, Key Competitors 14
Eurofins MWG Operon LLC, Other Locations 15
Eurofins MWG Operon LLC, Subsidiaries 15

List of Figures
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eurofins MWG Operon LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eurofins MWG Operon LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Eurofins MWG Operon LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Reliance Industries Ltd (RELIANCE):企業の財務・戦略的SWOT分析
    Reliance Industries Ltd (RELIANCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on …
  • Indianapolis Power & Light Co:企業の発電所・SWOT分析2018
    Indianapolis Power & Light Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Roper Technologies Inc (ROP):企業の財務・戦略的SWOT分析
    Roper Technologies Inc (ROP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • BYD Co Ltd (1211):企業の財務・戦略的SWOT分析
    BYD Co Ltd (1211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • JXTG Holdings Inc (5020):企業の財務・戦略的SWOT分析
    JXTG Holdings Inc (5020) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Coloplast AS (COLO B):医療機器:M&Aディール及び事業提携情報
    Summary Coloplast A/S (Coloplast) is a medical device company that offers products and services for ostomy care, urology care, continence care, and skin and wound care. Its major products include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; advance …
  • Wolverine Power Supply Cooperative Inc:企業の戦略的SWOT分析
    Wolverine Power Supply Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Straco Corporation Limited:企業の戦略・SWOT・財務情報
    Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • John Wood Group Plc (WG.):電力:M&Aディール及び事業提携情報
    Summary John Wood Group plc (Wood) is a provider of project, engineering and technical services. The company offers comprehensive solutions that improve the performance of customers' industrial assets across the asset life cycle. Its services span from concept to decommissioning and include asset so …
  • Brooks Automation Inc (BRKS):企業の財務・戦略的SWOT分析
    Brooks Automation Inc (BRKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ANGLE plc (AGL):企業の製品パイプライン分析2018
    Summary ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of …
  • Atlas Genetics Ltd-医療機器分野:企業M&A・提携分析
    Summary Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposab …
  • National HealthCare Corp (NHC):企業の財務・戦略的SWOT分析
    Summary National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing, Alzheimer's and memory care, residential and assisted living, home care, hospice care and long term care insurance serv …
  • Escher Group Holdings plc:企業の戦略・SWOT・財務情報
    Escher Group Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Escher Group Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Rumex International Co:製品パイプライン分析
    Summary Rumex International Co (Rumex International) is a medical device company that manufactures and markets precision instruments for ophthalmology and cardiovascular surgery. The company provides products, which include blade holders, forceps, glaucoma instruments, hooks, lasik and lasek instrum …
  • OAO Tatneft:企業の戦略・SWOT・財務分析
    OAO Tatneft - Strategy, SWOT and Corporate Finance Report Summary OAO Tatneft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • SeaBird Exploration PLC (SBX):企業の財務・戦略的SWOT分析
    Summary SeaBird Exploration PLC (SeaBird) operates as an oil and gas company that offers marine seismic data services. The company’s services include 2D seismic acquisition, 3D and 3D shallow water acquisition and source vessel. Its source vessels offers services such as conventional undershoots, 4d …
  • The Walsh Group:企業の戦略的SWOT分析
    The Walsh Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Schiller AG:企業の戦略的SWOT分析
    Schiller AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆